NIHR Maudsley BRC Blog

Our latest news and events

Genetics helps estimate the risk of disease – but how much does it really tell us?

Genetics research has made momentous strides in the 21st century. At the start of the century, we had a broad understanding that most medical problems in the developed world are partly genetically determined but lacked the technology to fully explore the secrets hiding in our genome.

 

By NIHR Maudsley BRC at 26 Jan 2022

Bringing together imaging and genetic mapping to investigate patterns of vulnerability in the brain

Dr Daniel Martins is a Clinical Research Associate, Dr Mattia Veronese is a senior molecular imaging scientist and Dr. Ottavia Dipasquale is a Research Associate, all in the Department of Neuroimaging at King’s College London. In this blog they discuss their recent study which is funded by the NIHR Maudsley BRC and has brought together scientists from across the world to define a new approach to integrate neuroimaging and a form of genetic mapping.

By NIHR Maudsley BRC at 21 Jan 2022

Genetic risk of mental health conditions may influence where people choose to live, study suggests

Research on around 386,000 UK adults has found that a high genetic risk for schizophrenia and other mental health conditions, including bipolar disorder, anorexia and autism, is associated with living in and moving to urban areas. In contrast, people with low genetic risk of ADHD preferentially moved from rural/suburban environments to cities.

By NIHR Maudsley BRC at 25 Oct 2021

Genetic risks for depression differ between East Asian and European groups

Specific genes increase the risk of developing depression, according to a new study which also shows that the genes associated with depression vary depending on ancestry group.

By NIHR Maudsley BRC at 30 Sep 2021

Simple blood test can accurately reveal underlying neurodegeneration, according to new research

A new study of over 3000 people led by King’s College London in collaboration with Lund University, has shown for the first time that a single biomarker can accurately indicate the presence of underlying neurodegeneration in people with cognitive issues.

By NIHR Maudsley BRC at 7 Jun 2021